| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/21/1989 | US4806629 Hybric cell line-for diagnosis and therapy |
| 02/21/1989 | US4806628 Specific binding; diagnosis and treatment of melanomas |
| 02/21/1989 | US4806627 Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
| 02/21/1989 | US4806523 Cartilage-inducing factors |
| 02/21/1989 | US4806494 Monoclonal antibody against ovarian cancer cells (OVB-3) |
| 02/21/1989 | US4806492 Polypeptide tumor inhibitors and antibodies thereto |
| 02/21/1989 | US4806476 Removing calcium ions to destabilize cell membranes |
| 02/21/1989 | US4806465 Cytoplasmic antigens of candida albicans and methods of using the same |
| 02/21/1989 | US4806349 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
| 02/21/1989 | US4806346 Method for isolation of antigen specific immunoglobulin |
| 02/21/1989 | CA1250241A1 Method for differential diagnosis of t cell leukemias using monoclonal antibodies |
| 02/15/1989 | EP0303538A2 Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/15/1989 | EP0303463A2 Method to control leukocyte extravasation |
| 02/15/1989 | EP0303309A2 A genus-specific Listeria antigen identified by monoclonal antibodies |
| 02/15/1989 | EP0303088A2 Purified IgM |
| 02/15/1989 | EP0302928A1 Inorganic filtration membrane modified for protein separation. |
| 02/14/1989 | US4804746 Administering a decapeptide as a hapten with a carrier and a hapten-carrier binder |
| 02/14/1989 | US4804626 Using immobilized monoclonal antibodies |
| 02/14/1989 | CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 02/14/1989 | CA1250099A1 Immunogens, antibodies, labeled conjugates and related derivatives for lidocaine and analogs thereof |
| 02/09/1989 | WO1989001163A1 Method for assaying basic fetal protein in urine and assaying kit therefor |
| 02/09/1989 | WO1989001159A1 Receptor membranes |
| 02/09/1989 | WO1989001153A1 Methods for breast cancer detection |
| 02/09/1989 | WO1989001045A1 Leishmania-specific antigens, process for preparing them, antigenic profiles containing these antigens and their application to the diagnosis of visceral leishmaniasis |
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/09/1989 | DE3710309A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 02/08/1989 | EP0302734A2 Continuous processes for modifying biologically active materials and the products therefrom |
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 02/07/1989 | US4803262 Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods |
| 02/07/1989 | US4803167 Hybridoma culture product; treatment for congestive heart failure |
| 02/07/1989 | US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa |
| 02/07/1989 | CA1249811A1 Rigid coupling compounds |
| 02/07/1989 | CA1249781A1 Methods of concentrating ligands and active membranes used therefor |
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections |
| 02/01/1989 | EP0301992A2 Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor |
| 02/01/1989 | EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications |
| 02/01/1989 | EP0301954A2 Cloning method and expression of genes constituting functional organised structures |
| 02/01/1989 | EP0301777A1 Multiple membrane microencapsulation |
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 |
| 02/01/1989 | CN1030748A Vinyl substituted radiohalogen conjugates for protein labeling |
| 01/31/1989 | US4801687 Monoclonal antibody purification process using protein A |
| 01/31/1989 | US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication |
| 01/31/1989 | US4801450 High titer pseudomonas immune serum globulin |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000607A1 Preparation of human monoclonal antibodies of selected specificity and isotypes |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000446A1 Affinity separating using immobilized flocculating reagents |
| 01/26/1989 | WO1989000428A1 Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus |
| 01/26/1989 | WO1989000166A3 Growth hormone related peptide |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300740A2 Monoclonal antibodies to complement C5a |
| 01/25/1989 | EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins |
| 01/25/1989 | EP0300459A2 Human pancreatic secretory trypsin inhibitor |
| 01/25/1989 | EP0300102A1 Improved method of obtaining immune regulatory factors by mammal immunization |
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use |
| 01/25/1989 | EP0299965A1 Antigenic analogues of platelet activating factor (paf) |
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens |
| 01/25/1989 | CN1030611A Monoclonal antibody specific for adhesion function domain of phagocyte cell surface protein |
| 01/25/1989 | CN1030610A Monoclonal antibody specific to common determinant site of neutrophils and eosinophils |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone |
| 01/24/1989 | US4800078 Immunoglobulins |
| 01/24/1989 | CA1249395A1 Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/19/1989 | DE3722673A1 DNA coding for plasminogen activator inhibitor type 2 (PAI-2) |
| 01/19/1989 | DE3710430A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/19/1989 | DE3710364A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates |
| 01/17/1989 | USRE32833 Complementing set of monoclonal antibodies |
| 01/17/1989 | US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 01/17/1989 | US4798806 Compositions and methods using a monoclonal antibody to a human T cell antigen |
| 01/17/1989 | US4798800 Process for isolating human globular domain NC1 of basal membrane collagen from human tissue |
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen |
| 01/17/1989 | CA1249097A1 Polymers based on polyvinylene carbonate and/or polyhydroxymethylene, processes for their preparation and their use |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/17/1989 | CA1248893A1 Murine hybridoma lym-1 and diagnostic antibody produced thereby |
| 01/17/1989 | CA1248892A1 Murine hybridoma lym-2 and diagnostic antibody produced thereby |
| 01/12/1989 | WO1989000293A1 A method for sample extraction, purification, concentration and quantification of low molecular weight organic compounds and an analytical kit for carrying out said method |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000195A1 Process for immobilization of biological material by cross-linking with polyazetidine |
| 01/12/1989 | WO1989000190A1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
| 01/12/1989 | WO1989000169A1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
| 01/12/1989 | WO1989000166A2 Growth hormone related peptide |
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes |
| 01/12/1989 | WO1989000080A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/12/1989 | DE3721637A1 Gaseinlass fuer eine mehrzahl verschiedener reaktionsgase in reaktionsgefaesse Gas inlet for a plurality of different reactive gases in reaktionsgefaesse |
| 01/11/1989 | EP0298783A1 Method, device and kit for measurement of tissue plasminogen activator activity |
| 01/11/1989 | EP0298755A1 Protein conjugates and their preparation |
| 01/11/1989 | EP0298654A2 Use of antibody/antigen interactions to protect or modulate biological activity |
| 01/11/1989 | EP0298633A2 Synthetic polypeptides |
| 01/11/1989 | EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions |
| 01/11/1989 | EP0298210A2 Method for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and reagents used therefor |
| 01/11/1989 | EP0298101A1 Thiol-reactive cross-linking reagents |